Close Menu

NEW YORK — Biodesix said Wednesday it has entered a regulatory cooperation agreement with lab equipment firm Streck that will allow it to incorporate Streck's blood collection tubes (BCTs) into its sample collection protocols.

Biodesix said that the agreement will aid its efforts to win US Food and Drug Administration approval for lung cancer companion diagnostics using next-generation sequencing and droplet digital PCR.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Mar
31
Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.